Biotech and Pharmaceuticals Life Sciences

More

  • Corium reports 1Q loss Monday, 8 Feb 2016 | 4:14 PM ET

    MENLO PARK, Calif. _ Corium International Inc. on Monday reported a loss of $9.4 million in its fiscal first quarter. On a per-share basis, the Menlo Park, California- based company said it had a loss of 42 cents. Keywords: Corium International, Earnings Report.

  • Immunomedics reports 2Q loss Wednesday, 3 Feb 2016 | 4:43 PM ET

    MORRIS PLAINS, N.J. _ Immunomedics Inc. on Wednesday reported a loss of $13.7 million in its fiscal second quarter. On a per-share basis, the Morris Plains, New Jersey- based company said it had a loss of 15 cents. This story was generated by Automated Insights using data from Zacks Investment Research.

  • Theravance beats 4Q profit forecasts Wednesday, 3 Feb 2016 | 4:21 PM ET

    SOUTH SAN FRANCISCO, Calif. _ Theravance Inc. on Wednesday reported fourth-quarter net income of $4.3 million, after reporting a loss in the same period a year earlier. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 1 cent per share. This story was generated by Automated Insights using data from Zacks Investment...

  • Ex-drug exec Shkreli has $40 million trading loss - U.S. Wednesday, 3 Feb 2016 | 12:15 PM ET

    NEW YORK, Feb 3- Former pharmaceutical executive Martin Shkreli suffered a roughly $40 million drop in the value of a trading account used to secure his bail following his arrest on securities fraud charges, a U.S. prosecutor said on Wednesday. That caused the value of Shkreli's E* Trade brokerage account to drop to $4 million to $5 million, from the $45 million...

  • LONDON, Feb 3- The world is once again asking scientists and drugmakers to come up rapidly with a vaccine for a viral disease that, in the latest case, few people had heard of until a few weeks ago, and even fewer feared. Making a shot to generate an immune response against Zika virus, which is sweeping through the Americas, shouldn't be too hard in theory.

  • *Assembles eight-person team to look into practicalities. *Will reach conclusion on how to proceed in next few weeks. LONDON, Feb 3- Japan's leading drugmaker Takeda Pharmaceutical is investigating ways in which it might help make a Zika vaccine, becoming the latest company to study vaccine options for the mosquito-borne disease sweeping the Americas.

  • ChemChina to buy Sygenta for $43 billion Wednesday, 3 Feb 2016 | 1:19 AM ET
    ChemChina to buy Sygenta for $43 billion

    CNBC's Julia Chatterley reports from Basel on Syngenta and the takeover deal by ChemChina, a Chinese state-owned company.

  • GENEVA/ PARIS, Feb 2- The Zika virus could spread to Africa, Asia and southern Europe, the World Health Organization said on Tuesday, as major French drugmaker Sanofi SA and others joined the race to create a vaccine. A day after Geneva- based WHO declared an international public health emergency due to Zika's association with the birth defect microcephaly in...

  • LONDON, Feb 2- The world is once again asking scientists and drugmakers to come up rapidly with a vaccine for a viral disease that, in the latest case, few people had heard of until a few weeks ago, and even fewer feared. Making a shot to generate an immune response against Zika virus, which is sweeping through the Americas, shouldn't be too hard in theory.

  • Array BioPharma reports 2Q loss Tuesday, 2 Feb 2016 | 7:30 AM ET

    BOULDER, Colo. _ Array BioPharma Inc. on Tuesday reported a loss of $24.2 million in its fiscal second quarter. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share. Four analysts surveyed by Zacks expected $43.6 million.

  • PARIS/ LONDON, Feb 2- Sanofi has launched a project to develop a vaccine against the Zika virus in the most decisive commitment yet by a major vaccine producer to fight the disease linked to multiple birth defects in Brazil. The move comes a day after the World Health Organization declared the mosquito-borne Zika virus to be an international public health...

  • PARIS— Drugmaker Sanofi Pasteur said Tuesday it is launching an effort to research and develop a vaccine to prevent the Zika virus, after the World Health Organization declared a global emergency over its explosive spread across the Americas. Sanofi made the first dengue vaccine shot, licensed last year in Brazil after years of scientific struggle to develop...

  • Jan 29- Companies and scientists are racing to create a Zika vaccine as concern grows over the mosquito-borne virus that has been linked to severe birth defects and is spreading quickly through the Americas. Brazil, the hardest-hit country, has reported around 3,700 cases of the devastating birth defect called microcephaly that are strongly suspected to be...

  • FACTBOX-Race to develop Zika vaccine Friday, 29 Jan 2016 | 1:44 PM ET

    Jan 29- Drugmakers globally are racing to produce a vaccine for Zika, a mosquito-borne virus that has been linked to severe birth defects. The World Health Organization has warned the disease is spreading explosively through the Americas. But, companies and scientists have made clear that a vaccine for public use is, at the very least, some months away.

  • Hawaii Biotech joins race to develop Zika vaccine Friday, 29 Jan 2016 | 9:05 AM ET

    Jan 29- Privately owned vaccine developer Hawaii Biotech Inc has joined the race to produce a vaccine for the mosquito-borne Zika virus, a fast-spreading infection which has been linked to severe birth defects in babies. The company initiated a formal program to test a Zika vaccine last fall, as the virus began to gain traction in Brazil, said Chief Executive Dr.

  • Roche earnings miss forecasts Thursday, 28 Jan 2016 | 2:00 AM ET
    Roche earnings miss forecasts

    Severin Schwan, CEO of Roche, discusses his company's full year results, which came in below expectations.

  • Health tech: UK vs USA Wednesday, 27 Jan 2016 | 4:40 AM ET
    Health tech: UK vs USA

    The U.K. is becoming a test bed for developing and proving new digital technologies in health care says George Freeman MP, UK minister for life sciences, as he discusses health tech trends.

  • 2016 will be pivotal to health care: JP Morgan Wednesday, 27 Jan 2016 | 2:00 AM ET
    2016 will be pivotal to health care: JP Morgan

    Cathrin Petty, head of EMEA healthcare at JP Morgan, says 2016 will be a pivotal year for the health care industry due to new product launches and approvals, as well as commercial headwinds.

  • Jan 25- GlaxoSmithKline Plc is concluding feasibility studies evaluating whether its vaccine technology is suitable for the Zika virus, which has been linked to brain damage in thousands of babies in Brazil, a spokeswoman told Reuters. Zika will likely spread to all countries in the Americas except for Canada and Chile, the World Health Organization said on...

  • BOSTON, Jan 25- Zafgen's stock tumbled as much as 11.5 percent on Monday after hedge fund Kerrisdale Capital said it has a short bet on the biopharmaceutical company's stock, arguing that U.S. regulators will not approve the sale of its obesity drug. "Zafgen's deadly obesity drug has no reasonable chance of FDA approval," the hedge fund wrote in an 11- page report...